The Traderszone Network

Published in TZ Latest News 12 October, 2014 by The TZ Newswire Staff

1 Huge Risk Facing This Marijuana Stock

GW Pharmaceuticals Sativex was dealt a blow by U.K. regulators claiming that Sativex’s benefits don’t justify its cost.

read more